Diana Martin, MD
Pediatric Allergy/Immunology · Tampa, FLNPI 1780688432
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,182 of the $11,594 with a category attached, or 61.9%. 32 manufacturers reported payments, led by Genentech USA, Inc. at 40.1% of the total. 2025 is the largest year on record at $5,884, more than ten times the $327 reported in 2019.
Across 315 payments — averaging $36.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$5K
- GSK$975
- Sanofi$888
- AstraZeneca$844
- Takeda Pharmaceuticals U.S.A., Inc.$681
- Novartis$609
- plus $3K from 26 others
What the payments were for
- Consulting fees$3,84333%
- Travel & lodging$2462%
- Food & beverage$7,18262%
- Education$3243%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 18 | $4,647 |
| GSK | 42 | $975 |
| Sanofi | 42 | $888 |
| AstraZeneca | 30 | $844 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $681 |
| Novartis | 20 | $609 |
| Amgen(2 entities) | 20 | $432 |
| Regeneron Healthcare Solutions, Inc. | 12 | $342 |
| Pfizer | 16 | $304 |
| CSL Behring | 13 | $282 |
| Optinose US, Inc. | 11 | $204 |
| Covis Pharma GmbH | 7 | $161 |
| Sanofi-aventis U.S. LLC | 2 | $132 |
| Kaleo, Inc. | 7 | $131 |
| Phadia US Inc. | 6 | $115 |
| Teva Pharmaceuticals USA, Inc. | 6 | $96 |
| LEO Pharma Inc. | 4 | $91 |
| Biocryst US Sales Co., LLC | 3 | $85 |
| Pharming Healthcare, Inc. | 3 | $67 |
| Grifols USA, LLC | 3 | $65 |
| Galderma Laboratories, L.p. | 3 | $61 |
| Incyte Corporation | 1 | $58 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Blueprint Medicines Corporation | 2 | $49 |
| Ionis Pharmaceuticals, Inc. | 2 | $42 |
| ADMA Biomanufacturing LLC | 2 | $36 |
| Boehringer Ingelheim | 2 | $33 |
| Hikma Pharmaceuticals USA | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Organon | 1 | $22 |
| AbbVie | 1 | $17 |
| Alk-abello, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,594 in reported general payments places this provider in the 70th percentile of 30 pediatric allergy/immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DuleraMometasone/Formoterol | 24 | $8,765 |
| Azelastine Hcl | 24 | $721 |
| Fluticasone Propionate | 39 | $612 |
| Montelukast Sodium | 27 | $151 |
Paid to pharmacies, not to this prescriber.
Other pediatric allergy/immunology in Tampa
- Mark BallowTampa$324K
- Monica HajirawalaTampa$761
- Vivian Hernandez-TrujilloMiami Lakes$285K
- Jolan WalterSt Petersburg$232K
- Jennifer LeidingOrlando$214K
- Panida SriaroonSaint Petersburg$70K
- Hary KatzJacksonville$67K
- Jonathan MalkaNorth Miami Beach$32K
- Johana Castro WagnerLargo$15K
- Sharon LeonardJacksonville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.